Caricamento...
Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
The current focus in the treatment of papillary thyroid carcinoma (PTC) is tumor progression. The aim of this study was to build RNA-based classifiers and develop a comprehensive model to provide progression-free interval (PFI) risk prediction for PTC. The RNAseq data, miRNAseq data, and clinical in...
Salvato in:
| Pubblicato in: | Front Genet |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417634/ https://ncbi.nlm.nih.gov/pubmed/32849806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00805 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|